Dr Agarwals Eye Hospital Ltd.
Snapshot View

408.05 -0.05 ▼0.0%

03 August 2021, 04:00:00 P.M.
Volume: 1,497

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.dragarwal.com
Financial Indicators
Market Cap 191.81 Cr.
Earnings per share (EPS) 11.59 Trailing Twelve Months Ending 2021-06
Price-Earning Ratio (PE) 35.22 Trailing Twelve Months Ending 2021-06
Industry PE 205.26 Trailing Twelve Months Ending 2021-06
Book Value / Share 114.76 Trailing Twelve Months Ending 2021-06
Price to Book Value 3.56 Calculated using Price: 408.10
Dividend Yield 0.00 Period Ending 2020-03
No. of Shares Subscribed 0.47 Cr. 4,700,000 Shares
FaceValue 10
Company Profile

Dr.Agarwal's Eye Hospital has been promoted by Dr.J.Agarwal and his family members in 1994. Though the entire family has been in the profession of providing total eye care solutions for almost five decades prior to this, through various private limited company and partnership firms, owned by the family members. The Hospital has always been at the forefront of every medical advancement in the field of Ophthalmic care in the world and has several firsts to its credit. The Hospital is engaged in conducting continuous training and research and development programs and has over a period, developed an excellent team of highly skilled Ophthalmic specialists and surgeons, to assist in its growth plans.

The Hospital, after notching up an impressive success in TamilNadu, Anthra Pradesh and Rajasthan, is embarking on a major expansion program to increase its footprint to other parts of the country and renovation of its flagship facility at Chennai.

Dr. Agarwal's Eye Hospital is listed as 'A Major Eye Centre of the World' by The International Congress of Ophthalmology

Services offered by the company:

  • Intralase Surgery
  • Zyoptix / Lasik Laser
  • Customise your Eyes
  • Cataract Surgery
  • Phaco / Zyoptix Professional

Achievements/ recognition:-

1997:Prof.Amar Agarwal awarded at Coimbatore on 17/08/1997 for the CME conference speaking on lasik laser.

1998:Siva Reddy AwardProf.Amar Agarwal awarded at trichur-30.08.98- by the kerala state oph­thalmic conference for the best paper award- on favit- a new technique to remove dropped nuclei.

2003:Sandeep Wagh Gold MedalProf.Amar Agarwal awarded BY Pune Opthalmic Society and national institute of Opthalmology for his invention of PHAKONIT at Pune on 24th Aug 2003.

L V Pasricha Gold MedalProf. Amar Agarwal awarded by Haryana Opthalmic academy at the 18th anual conference at Haryana Opthalmic conference,Karnal on 25th May 2003 by Hon'ble shri.I D Swami, Minister of state of Home Affairs for the invention of Phakonit Technique.

2005:Outstanding Achievement AwardProf.Amar Agarwal awarded by Bombay ophthalmological association for his invention of microphakonit.This award was presented to him during their annual conference held from 4-6 November 2005 at Mumbai.

2006:Padmabushan Award Prof.Dr.J.Agarwal Receiving Padmabushan award from Hon'ble Dr.J.Abdul Kalam,President of India.

Rajiv Gandhi / G K Moopanar AwardProf.Amar Agarwal awarded by hon'ble union minister of state Mr.G.K.Vasan for his invention of mocrophanpkit.This award was presented to him during a meeting held on 26th aug.2006 at Chennai.

2007:Champion of Humanity AwardProf.Amar Agarwal awarded by Hindustan chamber of commerce for his contribution towards community ophthalmology.  This was presented to him by mr.vijaikumar bafna, president – Hindustan chamber of commerce on 2nd November 2007 at Chennai.

2008:Gold MedalProf.Amar Agarwal awarded the GOLD MEDAL by Bombay ophthalmic association at Mumbai on 20th September 2008.  This was given to him for his new innovation – glued iol.

Scientific Innovation AwardProf. Amar Agarwal awarded by the south Asian academy of opthalmology congress at Delhi on 23rd August 2008. This was awarded to him for his innovations in opthalmology.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
-0.01%
1 Week
+3.26%
1 Month
-9.12%
3 Month
+16.17%
6 Month
+5.47%
1 Year
+82.37%
2 Year
+40.27%
5 Year
+95.24%
9 years 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03
Return on Equity (%) 12.97 21.83 14.05 26.67 0.16 27.78 21.02 29.55 26.91
Return on Capital Employed (%) 18.12 19.22 16.58 18.81 7.70 28.26 31.70 34.30 39.87
Return on Assets (%) 2.81 5.20 3.74 8.53 0.05 8.87 7.65 11.01 9.55

Balance Sheet View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Shh. Funds 13 16 19 24 23 29 35 46 56
Non Curr. Liab. 15 13 12 13 25 24 24 40 71
Curr. Liab. 29 35 35 31 36 27 37 35 39
Minority Int.
Equity & Liab. 57 63 67 67 84 81 96 120 166
Non Curr. Assets 39 41 44 44 61 61 73 91 136
Curr. Assets 19 22 23 23 24 20 23 30 30
Misc. Exp. not W/O
Total Assets 57 63 67 67 84 81 96 120 166

Profit Loss View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Net Sales 104 109 113 118 137 149 153 170 176
Other Income 2 1 3 0 0 2 2 2 3
Total Income 106 110 116 118 137 150 156 172 179
Total Expenditure -92 -96 -102 -103 -121 -126 -129 -140 -129
PBIDT 13 14 14 15 15 24 27 32 50
Interest -5 -4 -4 -4 -5 -4 -3 -4 -9
Depreciation -6 -5 -6 -6 -11 -9 -10 -11 -21
Taxation -1 -1 -1 0 1 -4 -7 -6 -6
Exceptional Items
PAT 2 3 2 6 0 7 7 12 14

Cash Flow View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Cash Fr. Operatn. 11 11 12 14 17 20 19 25 39
Cash Fr. Inv. -4 -6 -11 -10 -17 -8 -11 -25 -17
Cash Fr. Finan. -7 -3 -3 -5 0 -12 -8 2 -20
Net Change 1 2 -3 -1 0 0 0 2 2
Cash & Cash Eqvt 4 6 3 1 2 2 2 4 6

Shareholding Pattern View Details

9 Qtrs 2019-06 (%) 2019-09 (%) 2019-12 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%)
Promoter 74.86 74.86 74.81 74.76 74.76 74.76 74.42 74.02 73.77
Public 25.14 25.14 25.19 25.24 25.24 25.24 25.58 25.98 26.23
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 95.86 95.86 98.75 98.82 98.82 98.82 99.27 99.81 99.57

Announcements View Details

Mon, 26 Jul 2021
Announcement under Regulation 30 (LODR)-Newspaper Publication
Publication of Un-audited Financial Results in the Newspaper for the Quarter ended 30th June 2021.
Fri, 23 Jul 2021
Unaudited Financial Results And Limited Review Report For The Quarter Ended June 30 2021- Outcome Of The Board Meeting
Approved the Un-audited financial results of the Company for the quarter ended June 30 2021.
Fri, 23 Jul 2021
Approved The Unaudited Financial Results And Limited Review Report For The Quarter Ended June 30 2021.
Approved the Unaudited Financial Results and Limited Review Report for the quarter ended June 30 2021.

Technical Scans View Details

Mon, 02 Aug 2021
High Delivery Percentage High Delivery Percentage
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Crossing 50 SMA From Above Close Crossing 50 SMA From Above
RSI Trending Down RSI Trending Down

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 185,816.50 794.85 +2.6%
Divi's Laboratories Ltd. 130,822.92 4,990.05 +1.3%
Dr. Reddy's Laboratories Ltd. 78,219.21 4,721.20 +0.4%
Cipla Ltd. 74,356.30 927.25 +0.6%
Cadila Healthcare Ltd. 60,574.85 592.10 +0.1%
Apollo Hospitals Enterprise Ltd. 58,218.41 4,076.05 +0.7%
Piramal Enterprises Ltd. 56,317.82 2,507.65 +0.7%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-06 30.95 794.85 +2.6%
Divi's Laboratories Ltd. Consolidated 2021-03 65.93 4,990.05 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-06 45.02 4,721.20 +0.4%
Cipla Ltd. Consolidated 2021-03 30.92 927.25 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 28.39 592.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 387.19 4,076.05 +0.7%
Piramal Enterprises Ltd. Consolidated 2021-03 42.27 2,507.65 +0.7%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-06 3.88 794.85 +2.6%
Divi's Laboratories Ltd. Consolidated 2021-03 14.08 4,990.05 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-06 4.37 4,721.20 +0.4%
Cipla Ltd. Consolidated 2021-03 4.06 927.25 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 4.66 592.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 12.67 4,076.05 +0.7%
Piramal Enterprises Ltd. Consolidated 2021-03 1.65 2,507.65 +0.7%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 0.18 794.85 +2.6%
Divi's Laboratories Ltd. Consolidated 2020-03 0.00 4,990.05 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 4,721.20 +0.4%
Cipla Ltd. Consolidated 2020-03 0.18 927.25 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 0.35 592.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 1.08 4,076.05 +0.7%
Piramal Enterprises Ltd. Consolidated 2021-03 1.16 2,507.65 +0.7%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 9.66 794.85 +2.6%
Divi's Laboratories Ltd. Consolidated 2020-03 19.30 4,990.05 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,721.20 +0.4%
Cipla Ltd. Consolidated 2020-03 10.09 927.25 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 18.30 592.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 13.08 4,076.05 +0.7%
Piramal Enterprises Ltd. Consolidated 2021-03 3.33 2,507.65 +0.7%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 10.07 794.85 +2.6%
Divi's Laboratories Ltd. Consolidated 2020-03 25.36 4,990.05 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 15.24 4,721.20 +0.4%
Cipla Ltd. Consolidated 2020-03 12.53 927.25 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 13.65 592.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 17.13 4,076.05 +0.7%
Piramal Enterprises Ltd. Consolidated 2021-03 10.03 2,507.65 +0.7%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 32,837.50 794.85 +2.6%
Divi's Laboratories Ltd. Consolidated 2020-03 5,394.42 4,990.05 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 4,721.20 +0.4%
Cipla Ltd. Consolidated 2020-03 17,131.99 927.25 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 15,102.20 592.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 11,246.80 4,076.05 +0.7%
Piramal Enterprises Ltd. Consolidated 2021-03 12,809.35 2,507.65 +0.7%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 4,186.79 794.85 +2.6%
Divi's Laboratories Ltd. Consolidated 2020-03 1,376.54 4,990.05 +1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 4,721.20 +0.4%
Cipla Ltd. Consolidated 2020-03 1,546.98 927.25 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 2,137.60 592.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 434.90 4,076.05 +0.7%
Piramal Enterprises Ltd. Consolidated 2021-03 1,074.43 2,507.65 +0.7%